JP2023520676A5 - - Google Patents

Info

Publication number
JP2023520676A5
JP2023520676A5 JP2022558017A JP2022558017A JP2023520676A5 JP 2023520676 A5 JP2023520676 A5 JP 2023520676A5 JP 2022558017 A JP2022558017 A JP 2022558017A JP 2022558017 A JP2022558017 A JP 2022558017A JP 2023520676 A5 JP2023520676 A5 JP 2023520676A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
antagonist
subject
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022558017A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520676A (ja
JP7902113B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024419 external-priority patent/WO2021195530A1/en
Publication of JP2023520676A publication Critical patent/JP2023520676A/ja
Publication of JP2023520676A5 publication Critical patent/JP2023520676A5/ja
Application granted granted Critical
Publication of JP7902113B2 publication Critical patent/JP7902113B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022558017A 2020-03-27 2021-03-26 Il-4rアンタゴニストを投与することによりアトピー性皮膚炎を処置するための方法 Active JP7902113B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063001224P 2020-03-27 2020-03-27
US63/001,224 2020-03-27
EP21315010.5 2021-01-28
EP21315010 2021-01-28
PCT/US2021/024419 WO2021195530A1 (en) 2020-03-27 2021-03-26 Methods for treating atopic dermatitis by administering an il-4r antagonist

Publications (3)

Publication Number Publication Date
JP2023520676A JP2023520676A (ja) 2023-05-18
JP2023520676A5 true JP2023520676A5 (cg-RX-API-DMAC7.html) 2024-04-03
JP7902113B2 JP7902113B2 (ja) 2026-08-07

Family

ID=75498103

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022558017A Active JP7902113B2 (ja) 2020-03-27 2021-03-26 Il-4rアンタゴニストを投与することによりアトピー性皮膚炎を処置するための方法

Country Status (11)

Country Link
US (1) US20230102151A1 (cg-RX-API-DMAC7.html)
EP (1) EP4126951A1 (cg-RX-API-DMAC7.html)
JP (1) JP7902113B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220158821A (cg-RX-API-DMAC7.html)
CN (1) CN115427450A (cg-RX-API-DMAC7.html)
AU (1) AU2021244266A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022015363A2 (cg-RX-API-DMAC7.html)
CA (1) CA3173173A1 (cg-RX-API-DMAC7.html)
IL (1) IL296214A (cg-RX-API-DMAC7.html)
MX (1) MX2022011730A (cg-RX-API-DMAC7.html)
WO (1) WO2021195530A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
CN118286417A (zh) 2012-09-07 2024-07-05 瑞泽恩制药公司 以il-4r拮抗剂治疗特应性皮炎的方法
TWI634900B (zh) 2013-07-11 2018-09-11 再生元醫藥公司 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
KR102872485B1 (ko) 2016-09-01 2025-10-20 리제너론 파아마슈티컬스, 인크. Il-4r 길항제를 투여함에 의해 알레르기를 예방하거나 치료하기 위한 방법
KR20210143246A (ko) 2019-03-21 2021-11-26 리제너론 파아마슈티컬스, 인크. 알레르기 치료용 il-4/il-13 경로 억제제 및 형질 세포 절제의 병용
JP7736667B2 (ja) 2019-08-05 2025-09-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Il-4rアンタゴニストを投与することによるアトピー性皮膚炎の治療方法
US20230167171A1 (en) 2021-08-23 2023-06-01 Regeneron Pharmaceuticals, Inc. Methods for treating atopic dermatitis by administering an il-4r antagonist
JP2025501239A (ja) * 2021-12-30 2025-01-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Il-4/il-13アンタゴニストを投与することによってアトピーマーチを減弱する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2990420T (pt) 2000-05-26 2017-03-16 Immunex Corp Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
UA93653C2 (ru) 2003-11-07 2011-03-10 Иммунекс Корпорейшн Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r)
US7459426B2 (en) * 2004-06-04 2008-12-02 Regeneron Pharmaceuticals, Inc. Methods of using IL-1 antagonists to treat autoinflammatory disease
CA2664343C (en) 2006-10-02 2016-04-26 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human il-4 receptor
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
US8092804B2 (en) 2007-12-21 2012-01-10 Medimmune Limited Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
MX366337B (es) 2010-10-06 2019-07-05 Regeneron Pharma Formulaciones estabilizadas que contienen anticuerpos anti-receptor de interleucina-4 (il-4r).
CN118286417A (zh) 2012-09-07 2024-07-05 瑞泽恩制药公司 以il-4r拮抗剂治疗特应性皮炎的方法
EP3416685B1 (en) * 2016-02-19 2024-06-26 Regeneron Pharmaceuticals, Inc. Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist
CN107474134B (zh) 2016-06-08 2021-07-27 苏州康乃德生物医药有限公司 用于结合白细胞介素4受体的抗体
PT3515465T (pt) 2017-08-18 2024-03-04 Regeneron Pharma Métodos para o tratamento de uma dermatite atópica grave mediante a administração de um inibidor de il-4r
MX2020012064A (es) * 2018-05-13 2021-04-13 Regeneron Pharma Metodos para tratar la dermatitis atopica administrando un inhibidor de il-4r.
KR102330596B1 (ko) 2018-11-09 2021-11-26 아주대학교산학협력단 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2025172841A5 (cg-RX-API-DMAC7.html)
JP2022543612A5 (cg-RX-API-DMAC7.html)
JP2021523188A5 (cg-RX-API-DMAC7.html)
US20240417455A1 (en) Treatment for rheumatoid arthritis
HRP20181227T1 (hr) Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r
JP6554155B2 (ja) Il−17アンタゴニストを使用して汎発性膿疱性乾癬(gpp)を処置する方法
RU2019111921A (ru) Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r
JP2024174962A5 (cg-RX-API-DMAC7.html)
JP2019529560A5 (cg-RX-API-DMAC7.html)
JP2021502349A5 (cg-RX-API-DMAC7.html)
JP2022126791A (ja) Il-17アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2024530954A5 (cg-RX-API-DMAC7.html)
JP2024532263A5 (cg-RX-API-DMAC7.html)
JP2023520676A (ja) Il-4rアンタゴニストを投与することによりアトピー性皮膚炎を処置するための方法
JP2024016237A5 (cg-RX-API-DMAC7.html)
CN104244978A (zh) 通过施用丝氨酸蛋白酶抑制剂治疗或预防流感病毒感染的方法
JP2025501239A5 (cg-RX-API-DMAC7.html)
JP2021147383A (ja) アトピー性皮膚炎及び関連障害を処置するための方法
EP4126943B1 (en) Methods for treating atopic dermatitis and related disorders
RU2024129648A (ru) Способы лечения атопического дерматита посредством введения антагониста il-4r
RU2022105374A (ru) Способы лечения атопического дерматита посредством введения антагониста il-4r
RU2024107446A (ru) Способы лечения атопического дерматита посредством введения антагониста il-4r
RU2024121393A (ru) Способы ослабления атопического марша посредством введения антагониста il-4/il-13
RU2020140639A (ru) Способы лечения атопического дерматита посредством введения ингибитора ил-4r
NZ769607B2 (en) Methods for treating atopic dermatitis by administering an il-4r inhibitor